TCT 1134: Long  term outcomes of TAVR in Bicuspid aortic valve based on morphology

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences</li></ul>